Clinical Trials for Alector

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alector

Clinical Trials (4)

NCT07105709
Open-label Extension Study in Participants With Early Alzheimer's Disease
PHASE2Recruiting
297 participants
Started: Aug 14, 2025 · Completed: Nov 24, 2028
1 condition2 sponsors5 locations
NCT06111014
Continuation Study for Latozinemab
PHASE3Enrolling by invitation
35 participants
Started: Dec 8, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor18 locations
NCT06079190
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
PHASE2Active, not recruiting
367 participants
Started: Oct 20, 2023 · Completed: Nov 23, 2026
1 condition2 sponsors97 locations
NCT04374136
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
PHASE3Active, not recruiting
110 participants
Started: Jul 23, 2020 · Completed: Aug 3, 2027
1 condition2 sponsors44 locations